In view of an efficient use of the Italian National Health Service-funded healthcare resources, a novel data-processing strategy combining information from multiple sources was developed in a regional cancer network of northern Italy. The goal was to calculate the annual overall cost of care pathways of six disease groups in 10,486 patients. The evaluation was conceived as a population-based cost description from the perspective of the Italian National Health Service. Costs occurred during a defined time period for a cross-section of patients at varying stages of their disease were measured. The total cancer care cost was €81,170,121 (11.1% of total local health expenditure), with a cost per patient of €7741.17 and a cost per capita of €204.62. Surgical, inpatient and day-hospital medical admissions, radiotherapy, drugs, outpatient care, emergency admissions, and home and hospice care accounted for 21.2%, 24.1%, 6.2%, 28.2%, 14.0%, 0.9%, and 5.4% of the total cost, respectively. The highest cost items included drugs (cost per capita, €22.95; 11.2% of total cost) and medical admissions (€14.51; 7.1%) for blood cancer, and surgical (€14.56; 7.1%) and medical admissions (€13.60; 6.6%) for gastrointestinal cancer. The information extracted allows multidisciplinary cancer care teams to be more aware of the costs of their clinical decisions.

中文翻译：

---

在特定疾病的癌症护理途径中评估癌症护理费用。

考虑到有效利用意大利国家卫生服务局资助的医疗资源，在意大利北部的区域癌症网络中开发了一种结合多种来源信息的新型数据处理策略。目的是计算10486名患者中六个疾病组的年度护理总费用。从意大利国家卫生服务局的角度，该评估被认为是基于人群的成本描述。测量了在特定时间段内不同疾病阶段患者的成本。癌症护理总费用为81,170,121欧元（占当地卫生总费用的11.1％），每位患者的费用为7741.17欧元，人均费用为204.62欧元。外科，住院和日间住院医疗，放疗，药物，门诊护理，急诊，家庭和临终护理分别占总费用的21.2％，24.1％，6.2％，28.2％，14.0％，0.9％和5.4％。费用最高的项目包括药物（人均费用，22.95欧元；占总费用的11.2％）和血液癌的医疗费用（14.51欧元； 7.1％），以及外科手术（14.56欧元； 7.1％）和医疗费用（13.60欧元； 6.6％）用于胃肠道癌。提取的信息使跨学科的癌症护理团队能够更加了解其临床决策的成本。6％）用于胃肠道癌。提取的信息使多学科的癌症护理团队能够更加了解其临床决策的成本。6％）用于胃肠道癌。提取的信息使跨学科的癌症护理团队能够更加了解其临床决策的成本。